The global positron emission tomography (PET) scanners market size was US$ 1.95 billion in 2022. The global market size is forecast to reach US$ 3.11 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period from 2023 to 2031.
Nuclear medicine and biochemical analysis are combined in positron emission tomography (PET), which is used to measure the metabolic activity of cells. Through an intravenous (IV) line, a small dose of radioactive glucose (sugar) is supplied to the patient. With the use of a scanner and computer, detailed images of the glucose-containing regions are produced. Early identification of cancer, brain illnesses, and heart issues is possible with PET.
Market Driving Factors
The market is expanding due to the increasing incidence of breast cancer worldwide. The World Health Organization estimates that 2.3 million women worldwide were affected by breast cancer in 2020, contributing to 685,000 fatalities. 7.8 million women will have received a breast cancer diagnosis by the end of 2020. Imaging biomarkers have offered therapeutically valuable data for the detection and management of breast cancer. Regarding PET-based imaging of breast cancer, numerous studies have been published, and products have been introduced.
One of the factors fueling the market's expansion is the increasing need for PET analysis in radiopharmaceuticals. According to the World Nuclear Organization, the number of nuclear medicine procedures performed annually among the 311 million Americans is around 20 million, among the 500 million Europeans is about 10 million, and the 21 million Australians are about 560,000, which will help the market develop.
On the other hand, the strict regulatory guidelines and expensive scanner costs may slow down the overall market growth.
In the upcoming years, the market is likely to rise as PET and X-ray transmission computed tomography (CT) scans become more widely used. High diagnostic sensitivity and specificity are produced by this ground-breaking technology, which also shortens acquisition times and offers precise attenuation correction and fusion imaging. Furthermore, by defining prognostic and treatment monitoring capabilities of the functional and metabolic information provided by conventional nuclear imaging modalities, the combination of PET and CT aids in the better staging of disease.
Market Segmentation Breakthrough
By Application Breakthrough
In 2022, the oncology segment dominated the global market. This is due to the rising demand for effective and efficient diagnostic methods that minimize radiation exposure and the increasing prevalence of cancer cases worldwide. According to scholarly research published in the American Cancer Society magazine A Cancer Journal for Clinicians, in the United States, there were 608,570 cancer-related deaths and an expected 1.9 million new cancer cases in 2021. A radioactive substance or tracer is used in PET scanners to display both aberrant and typical metabolic activity.
By End-User Breakthrough
Over the forecast period, diagnostic imaging centers are likely to grow at the quickest rate. In order to give patients a wider variety of diagnostic alternatives, diagnostic imaging clinics are increasing their range of services. With the addition of the PET scan imaging approach, these facilities may now provide more thorough testing for a wide range of disorders. Additionally, PET scanners were previously expensive and were mostly used in hospitals. However, due to advances in technology, diagnostic imaging centers are now able to purchase PET scanners and attempt to offer imaging services to their customers at a lower cost.
Geographical Insights
In 2022, North America had the highest revenue share. This is due to the region's superior healthcare infrastructure and the quick technology advancements in the medical imaging and diagnostics sector.
Additionally, the improved financial resources of North American governments may favorably affect the market for PET scanners in the region. For instance, the provincial government in Canada gave the Western Regional Hospital Foundation USD 2 million in January 2021 to be used to purchase a PET scanner for the new intensive care hospital in Corner Brook.
List of Leading Companies
Segmentation Outline
The global positron emission tomography (PET) scanners market segmentation focuses on Product Type, Application, Detector Type, End User, and Region.
By Product Type
By Application
By Detector Type
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 FULL-RING PET SCANNER
5.3 PARTIAL-RING PET SCANNER
6 GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 ONCOLOGY
6.3 CARDIOLOGY
6.4 NEUROLOGY
6.5 OTHERS
7 GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET, BY DETECTOR TYPE
7.1 OVERVIEW
7.2 BISMUTH GERMANIUM OXIDE
7.3 LUTETIUM OXYORTHOSILICATE
7.4 GADOLINIUM OXYORTHOSILICATE
7.5 LUTETIUM FINE SILICATE
7.6 LUTETIUM YTTRIUM ORTHOSILICATE
8 GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 DIAGNOSTIC CENTERS
8.4 PET CENTERS
8.5 RESEARCH INSTITUTE
9 GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3.1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
10.4 COMPETITIVE DASHBOARD
10.5 PRODUCT MAPPING
10.6 TOP PLAYER POSITIONING, 2022
10.7 COMPETITIVE HEATMAP
10.8 TOP WINNING STRATEGIES
11 COMPANY PROFILES
11.1 G.E. HEALTHCARE
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.2 TOSHIBA CORPORATION
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.3 KONINKLIJKE PHILIPS N.V.
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.4 SIEMENS HEALTHINEERS
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.5 HITACHI MEDICAL CORPORATION
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.6 POSITRON CORPORATION
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.7 MEDISO LTD.
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.8. YANGZHOU KINDSWAY BIOTECH CO., LTD
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved